IRIS
CALVISI, Diego Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.312
EU - Europa 2.203
AS - Asia 907
OC - Oceania 26
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 7
Totale 7.490
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.285
UA - Ucraina 929
CN - Cina 803
DE - Germania 343
IT - Italia 291
SE - Svezia 276
FI - Finlandia 124
FR - Francia 76
GB - Regno Unito 76
BE - Belgio 46
TR - Turchia 32
CA - Canada 25
AU - Australia 24
DZ - Algeria 21
ID - Indonesia 17
IN - India 17
IR - Iran 12
EU - Europa 10
RO - Romania 8
RU - Federazione Russa 6
SG - Singapore 6
BD - Bangladesh 5
ES - Italia 4
NL - Olanda 4
AT - Austria 3
HK - Hong Kong 3
HU - Ungheria 3
IL - Israele 3
JP - Giappone 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
BR - Brasile 2
DK - Danimarca 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PL - Polonia 2
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
IQ - Iraq 1
IS - Islanda 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 7.490
Salva come PNG Salva come JPEG
Città #
Chandler 1.421
Jacksonville 526
Princeton 375
Nanjing 218
Wilmington 169
Sassari 167
Ann Arbor 162
Dearborn 148
Beijing 96
Ashburn 80
Boardman 80
Nanchang 77
Woodbridge 54
Shenyang 52
Hebei 46
Brussels 45
Changsha 45
Tianjin 42
New York 39
Jinan 37
Jiaxing 35
Norwalk 32
Andover 29
Falls Church 29
Izmir 28
Mountain View 28
Ningbo 22
Algiers 21
Toronto 21
Hangzhou 20
Kunming 20
San Francisco 18
Guangzhou 17
Zhengzhou 17
Leawood 15
Augusta 14
San Mateo 14
Taizhou 14
Auburn Hills 12
Los Angeles 11
Monmouth Junction 11
Ardabil 10
Houston 10
Melbourne 10
Helsinki 9
Lanzhou 9
Changchun 8
Fairfield 8
Haikou 8
Washington 7
Canberra 5
Singapore 5
Berlin 4
Chicago 4
Hanover 4
Marrùbiu 4
Rome 4
Seattle 4
Tappahannock 4
West Jordan 4
Cagliari 3
Central 3
Frankfurt am Main 3
Grézieu-la-varenne 3
Messina 3
Perugia 3
Stockholm 3
Torino 3
Vienna 3
Alghero 2
Auckland 2
Beinasco 2
Cambridge 2
Città Di Castello 2
Como 2
Dhaka 2
IJsselstein 2
Lappeenranta 2
London 2
Madrid 2
Mumbai 2
Orani 2
Raleigh 2
Redwood City 2
Santa Clara 2
Sezze 2
Shanghai 2
Sucre 2
Sydney 2
São Paulo 2
Taiyuan 2
Uta 2
Abuja 1
Agropoli 1
Amsterdam 1
Atlanta 1
Baghdad 1
Baltimore 1
Brierley Hill 1
Budapest 1
Totale 4.509
Salva come PNG Salva come JPEG
Nome #
Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma 89
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 86
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 85
Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain 77
Role of HSP90,CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer 76
Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-kappa B and Mat1A genes in the early stages of rat liver carcinogenesis 76
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans 69
Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumor formation in mice via AKT2/mTORC1 cascade. 68
Frequent loss of heterozygosity at the Hcr1 (Hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain 66
Hydrodynamic transfection for generation of novel mouse models for liver cancer research. 65
Alterations of methionine metabolism in hepatocarcinogenesis: the emergent role of glycine N-methyltransferase in liver injury 64
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 63
Application of comparative functional genomics to identify best-fit mouse models to study human cancer 63
Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma 62
Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines 62
Analysis of loss of heterozygosity in neoplastic nodules induced by diethylnitrosomine in the resistant BFF1 rat strain 62
Experimental models to define the genetic predisposition to liver cancer 62
4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras protooncogenes 61
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans 61
Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease 58
Lessons from rare tumors: Hepatic lymphoepithelioma-like carcinomas 58
MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes 58
[11C]acetate PET Imaging is not Always Associated with Increased Lipogenesis in Hepatocellular Carcinoma in Mice. 57
Loss of Fbxw7 synergizes with activated AKT signaling to promote c-Myc dependent cholangiocarcinogenesis 57
Beta catenin or genomic instability define two categories of liver cancer in transgenic mice 56
Classification and survival prediction of hepatocellular carcinoma by gene expression profiling 56
Implication of Bcl 2 family genes in basal and D amphetamine induced apoptosis in preneoplastic and neoplastic rat liver lesions 56
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans 56
Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital 56
Identification of genetic loci controlling hepatocarcinogenesis on rat chromosomes 7 and 10 55
5' Methylthioadenosine administration prevents lipid peroxidation and fibrogenesis induced in rat liver by carbon tetrachloride intoxication 55
Hepatocarcinogenesis following pancreatic islet transplantation in streptozotocin- and autoimmune-diabetic rats 55
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B 54
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells 54
Disregulation of E-cadherin in transgenic mouse models of liver cancer 54
Phenotypic reversion of rat neoplastic liver nodules is under genetic control 53
Identification and chromosome mapping of loci predisposing to colorectal cancer that control Wnt/b-catenin pathway and progression of early lesions in the rat 53
Activation of β-Catenin and Yap1 in Human Hepatoblastoma and Induction of Hepatocarcinogenesis in Mice. 53
E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer 52
p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer. 52
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis 52
SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis 52
The mTORC2-Akt1 Cascade Is Crucial for c-Myc to Promote Hepatocarcinogenesis in Mice and Humans 52
Dual-Specific Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase-Mediated control of Grawth in Human Hepatocellular Carcinoma 52
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells 52
Altered methionine metabolism and global DNA methylation in liver cancer: Relationship with genomic instability and prognosis 51
Long-term dehydroepiandrosterone and 16alfa-fluoro-5-androsten-17-one administration enhances DNA synthesis and induces expression of c-fos and c-Ha-ras in a selected population of preneoplastic lesions in liver of diethylnitrosamine-initiated rats 51
Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma 50
Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis 50
Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis 50
Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide 50
Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma 49
Activation of the canonical Wnt/Beta-catenin pathway confers growth advantages in c-My/E2F1 transgenic mouse model of liver cancer 49
Epigenetics of liver cancer progression: Role of transcriptional and post-transcriptional regulation of methionine adenosyltransferases in liver cancer progression. 49
Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice 49
Disregulation of DNA repair pathways in TGF-alfa/c-myc transgenic mouse model of accelerated hepatocarcinogenesis 49
Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma 49
Transferrin and transferrin receptor gene expression and iron upteke in hepatocellular carcinoma in the rat 48
The dark side of the moon: AKT as a tumor suppressor in the liver? 48
Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways. 48
Mapping a sex-hormone sensitive gene determining female resistance to liver carcinogenesis in a congenic F344 BN-Hcs4 rat. 48
AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways. 48
Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer 47
Combined CDK4/6 and pan-mTOR inhibition is synergistic against intrahepatic cholangiocarcinoma 47
An infernal cross-talk between oncogenic β-catenin and c-Met in hepatocellular carcinoma: Evidence from mouse modeling 47
Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value 46
Programmed death ligand 1 expression in hepatocellular carcinoma: A prognostic marker and therapeutic target for liver cancer? 46
The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models 46
AKT/mTOR activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis. 46
Activation of Beta-Catenin During Hepatocarcinogenesis in Transgenic Mouse Models: Relationships to Phenotype and Tumor Grade 46
Ubiquitous activation of Ras and Jak/Stat pathways in human HCC 45
Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: Novel insights from interspecies comparison 45
SKP2 cooperates with N-Ras or AKT to induce liver tumor development in mice 45
Aurora A regulates prometaphase progression by inhibiting the ability of RASSF1A to suppress APC-Cdc20 activity 45
Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control 44
Bmi1 is required for hepatic progenitor cell expansion and liver tumor development. 44
Role of transcriptional and postttranscriptional regulation of methionine adenosyltransferases in liver cancer progression. 44
Molecular and metabolic changes in human liver clear cell foci resemble the alterations occurring in rat hepatocarcinogenesis. 44
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice 44
Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in hepatocarcinogenesis: implications for the treatment of human liver cancer. 44
Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/mTORC1 cascade 44
Sulfatase 1: A new Jekyll and Hyde in hepatocellular carcinoma? 44
Polygenic control of hepatocarcinogenesis in Copenhagen x F344 rats 43
NORE1A Tumor Suppressor Candidate Modulates p21CIP1 via p53 43
Accomplices in crime: The diabolical liaison between protein tyrosine phosphatase 1B and ras in hepatocellular carcinoma 43
Molecular mechanisms of liver carcinogenesis in transgenic mouse models of liver cancer 43
SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model 43
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype 43
EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent stabilization of MDM4 in hepatocellular carcinoma. 42
Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease 42
TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma 42
Non-functioning gastroenteropancreatic (GEP) tumors: a 111In-Pentetreotide SPECT/CT diagnostic study. 42
Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver 41
PI3K/AKT/mTOR pathway plays a major pathogenetic role in glycogen accumulation and tumor development in renal distal tubules of rats and men. 41
Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targets 41
Hepatocellular carcinoma as a complex polygenic disease. Interpretative analysis of recent developments on genetic predisposition 41
The RASSF1A tumor suppressor activates Bax via MOAP-1 40
DNA-PKcs: A promising therapeutic target in human hepatocellular carcinoma? 40
Administration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer Cells 40
Role of perturbation of methionine metabolism and global DNA methylation in the generation of genomic instability in transgenic mouse models of liver cancer 40
Totale 5.224
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.011
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.011
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019200 0 0 0 0 0 0 0 0 0 0 5 195
2019/20201.394 329 6 102 10 133 129 264 25 161 64 165 6
2020/20211.446 143 5 243 11 144 101 189 8 225 215 134 28
2021/20221.068 125 9 6 10 23 36 53 65 110 55 116 460
2022/20232.409 254 219 143 407 193 384 3 248 373 10 94 81
2023/2024397 115 37 16 25 103 25 3 59 0 12 2 0
Totale 7.711